Qayoom H - Search Results

1

Exploring HMMR as a therapeutic frontier in breast cancer treatment, its interaction with various cell cycle genes, and targeting its overexpression through specific inhibitors.

Shabir A, Qayoom H, Haq BU, Abo Mansoor A, Abdelrahim A, Ahmad I, Almilabairy A, Ahmad F, Mir MA. Shabir A, et al. Among authors: qayoom h. Front Pharmacol. 2024 Mar 21;15:1361424. doi: 10.3389/fphar.2024.1361424. eCollection 2024. Front Pharmacol. 2024. PMID: 38576486 Free PMC article.

2

Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology.

Jan N, Sofi S, Qayoom H, Shabir A, Haq BU, Macha MA, Almilaibary A, Mir MA. Jan N, et al. Among authors: qayoom h. Heliyon. 2024 Jan 14;10(3):e24670. doi: 10.1016/j.heliyon.2024.e24670. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38314272 Free PMC article. Review.

3

Targeting p53 misfolding conundrum by stabilizing agents and their analogs in breast cancer therapy: a comprehensive computational analysis.

Haq BU, Qayoom H, Sofi S, Jan N, Shabir A, Ahmad I, Ahmad F, Almilaibary A, Mir MA. Haq BU, et al. Among authors: qayoom h. Front Pharmacol. 2024 Jan 10;14:1333447. doi: 10.3389/fphar.2023.1333447. eCollection 2023. Front Pharmacol. 2024. PMID: 38269278 Free PMC article.

4

Decoding the molecular mechanism of stypoldione against breast cancer through network pharmacology and experimental validation.

Qayoom H, Alshehri B, Ul Haq B, Almilaibary A, Alkhanani M, Ahmad Mir M. Qayoom H, et al. Saudi J Biol Sci. 2023 Dec;30(12):103848. doi: 10.1016/j.sjbs.2023.103848. Epub 2023 Oct 21. Saudi J Biol Sci. 2023. PMID: 37964781 Free PMC article.

5

Targeting breast cancer stem cells through retinoids: A new hope for treatment.

Jan N, Sofi S, Qayoom H, Haq BU, Shabir A, Mir MA. Jan N, et al. Among authors: qayoom h. Crit Rev Oncol Hematol. 2023 Dec;192:104156. doi: 10.1016/j.critrevonc.2023.104156. Epub 2023 Oct 10. Crit Rev Oncol Hematol. 2023. PMID: 37827439 Review.

6

Elucidation of interleukin-19 as a therapeutic target for breast cancer by computational analysis and experimental validation.

Sofi S, Jan N, Qayoom H, Alkhanani M, Almilaibary A, Ahmad Mir M. Sofi S, et al. Among authors: qayoom h. Saudi J Biol Sci. 2023 Sep;30(9):103774. doi: 10.1016/j.sjbs.2023.103774. Epub 2023 Aug 11. Saudi J Biol Sci. 2023. PMID: 37675062 Free PMC article.

7

Mechanistic elucidation of Juglanthraquinone C targeting breast Cancer: A network Pharmacology-based investigation.

Qayoom H, Alkhanani M, Almilaibary A, Alsagaby SA, Mir MA. Qayoom H, et al. Saudi J Biol Sci. 2023 Jul;30(7):103705. doi: 10.1016/j.sjbs.2023.103705. Epub 2023 Jun 15. Saudi J Biol Sci. 2023. PMID: 37425621 Free PMC article.

8

A network pharmacology-based investigation of brugine reveals its multi-target molecular mechanism against Breast Cancer.

Qayoom H, Alkhanani M, Almilaibary A, Alsagaby SA, Mir MA. Qayoom H, et al. Med Oncol. 2023 Jun 12;40(7):202. doi: 10.1007/s12032-023-02067-w. Med Oncol. 2023. PMID: 37308611

9

Targeting tumor microenvironment using tumor-infiltrating lymphocytes as therapeutics against tumorigenesis.

Qayoom H, Sofi S, Mir MA. Qayoom H, et al. Immunol Res. 2023 Aug;71(4):588-599. doi: 10.1007/s12026-023-09376-2. Epub 2023 Apr 1. Immunol Res. 2023. PMID: 37004645 Review.

10

Expression patterns and therapeutic implications of CDK4 across multiple carcinomas: a molecular docking and MD simulation study.

Qayoom H, Mehraj U, Sofi S, Aisha S, Almilaibary A, Alkhanani M, Mir MA. Qayoom H, et al. Med Oncol. 2022 Jul 23;39(10):158. doi: 10.1007/s12032-022-01779-9. Med Oncol. 2022. PMID: 35870089

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page